Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01112839 · ClinicalTrials.gov registry record · NA
Reducing Breast Cancer Recurrence With Weight Loss
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 692
- Enrollment target
NCT01112839: Completed NA study, sponsored by University of California, San Diego.
NCT01112839 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 692 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01112839, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 692 participants
- Enrollment target
Study Summary
The purpose of the ENERGY trial is to explore whether two different programs that are focused on weight management, through increased exercise and a healthy diet, are feasible, and have an impact on body weight, quality of life and fatigue. Since obesity among breast cancer survivors is associated with recurrence and other co-morbidities, those will be assessed and their impact calculated. Blood samples will be collected to enable analysis of potential mechanisms and differential response across subgroups.
Interventions
- BEHAVIORAL Less Intensive
- BEHAVIORAL Intensive Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 692 participants |
| Start Date | 2010-05 |
| Est. Completion | 2015-02 |
| Phase | NA |
What the finished NCT01112839 record still lists
NCT01112839 is an interventional study that assigns participants to a tested intervention. The registered 692 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% lower).
The record links to 0 conditions, and to 2 interventions - of which Less Intensive is the first listed.
NCT01112839 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01112839 about?
NCT01112839 is a clinical study titled "Reducing Breast Cancer Recurrence With Weight Loss". The purpose of the ENERGY trial is to explore whether two different programs that are focused on weight management, through increased exercise and a healthy diet, are feasible, and have an impact on body weight, quality of life and fatigue. Since obesity among breast cancer survivors is associated w...
What is the current status of trial NCT01112839?
This trial is currently completed. It is a NA study. The enrollment target is 692 participants. The study started on 2010-05. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01112839?
The interventions under investigation include: Less Intensive (BEHAVIORAL), Intensive Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01112839?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01112839's enrollment target sits among peer trials
692 151st of 2000 higher than 1,850 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07382167 · 692 participants · Phase 3
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
- NCT07179016 · 693 participants · NA
Evaluating the Auricular Point Acupressure-Self Management Program for Chronic Musculoskeletal Pain Among Rural Populations
- NCT00532051 · 690 participants
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
- NCT05184335 · 690 participants · Phase 3
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia